Skip to content

A community-led and digitally-aided support system for improved management of cardiovascular health in the Caribbean: A household approach that starts at pregnancy and extends to the family

A cluster randomised type 2 implementation-effectiveness trial of a community-based digital intervention to improve cardiovascular health in the first year after birth in women who experience a high-risk pregnancy and their household members in the Caribbean (Jamaica, Guyana, St Vincent and the Grenadines and Dominica)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN80179829
Enrollment
1704
Registered
2026-04-29
Start date
2026-09-15
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiometabolic risk factors, including hypertension, dysglycaemia, hypercholesterolaemia, overweight and obesity, tobacco consumption, sedentary lifestyle, poor sleep, poor diet in women who experience an adverse pregnancy outcome (hypertensive disorder of pregnancy, gestational diabetes, preterm birth, fetal growth restriction, and obesity) and an adult household member. Pregnancy and Childbirth

Interventions

This is a cluster randomised trial to evaluate a complex intervention delivered through the routine health services in each of the four countries. Clustering will be at the level of the Primary Health

Sponsors

University of the West Indies
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Eligible women will be those with one or more high-risk features in their pregnancy, including: 1. Any diagnosis of a hypertensive disorder of pregnancy (gestational hypertension, preeclampsia, eclampsia) or chronic hypertension diagnosed before pregnancy 2. Diagnosis of Gestational Diabetes Mellitus (GDM) during pregnancy as per local criteria, or prediabetes 3. Preterm delivery <37 weeks 4. Fetal growth restriction, defined as evidence of growth faltering or abnormal umbilical artery Dopplers on ultrasound, or size at birth of the baby < 10th percentile for gestational age and sex using the locally applied size at birth chart (or INTERGROWTH-21st chart if none is available) 5. Obesity as captured by the Body Mass Index (BMI) =30 kg/m2 or =25 kg/m2 in people of Caribbean-Indian or Asian ancestry. 6. Age over 18 years 7. Able to comprehend English Inclusion Criteria for adult household members: 1. Any adult resident in the same dwelling, or with whom regular meals are shared 2. Aged over 18 years 3. Able to comprehend English

Exclusion criteria

Exclusion criteria: Exclusion Criteria for postpartum women: 1. Frequent regular travel outside of the country 2. Plan to move to another region of the country in the next 6 months 3. Inability or unwillingness to provide informed consent 4. No intention to receive care at a primary health centre 5. Type 1 diabetes (pre-pregnancy) on insulin. Exclusion Criteria for adult household members: 1. Frequent regular travel outside of the country 2. Plan to move to another region of the country in the next 6 months 3. Inability or unwillingness to provide informed consent 4. No intention to receive care at a primary health centre 5. Existing cardiovascular disease or diabetes under the care of a specialist 6. Existing severe illness (e.g. cancer, major mental disorder) that would affect the ability to participate in the trial

Design outcomes

Primary

MeasureTime frame
Change in Life's Essential 8 cardiovascular risk score in women following an adverse pregnancy outcome measured using American Heart Association Life's Essential 8 Score at 12 months

Secondary

MeasureTime frame
Change in Life's Essential 8 cardiovascular risk score in household member of the postpartum woman measured using American Heart Association Life's Essential 8 Score at 12 months;Change in Life's Essential 8 cardiovascular risk score in women following an adverse pregnancy outcome measured using American Heart Association Life's Essential 8 Score at 6 months;Implementation measures of the trial measured using the RE-AIM framework at 6 and 12 months;Economic evaluation of the intervention compared to usual care measured using direct and indirect costs to the participants and health system at 6 and 12 months

Countries

Dominica, Guyana, Jamaica, Saint Vincent and the Grenadines

Contacts

Public ContactJacki Wynter
jackiwynter@gmail.com+1-246-417-4816

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jul 23, 2026